Legal Representation
Attorney
Natasha Reed
USPTO Deadlines
Next Deadline
108 days remaining
NOA E-Mailed - SOU Required
Due Date
November 20, 2025
Extension Available
Until May 20, 2026
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 20, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 25, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 25, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 19, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 3, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 3, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 3, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 3, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 3, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 14, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 14, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 14, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 13, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 22, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 22, 2024 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Apr 29, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals used as supplements in genetic therapy and immunotherapy therapy
Class 009
Downloadable computer software which allows users to receive personalized medicine; downloadable computer software which allows users to input personal health information, symptoms and receive information about customized and personalized medicine, both liquids or solids, with elements of ingredients and compositions, ratio of ingredients, and instructions on how to use it
Class 042
Product development in the field of identifying genetic therapy; research and development of technology in the field of genetic therapy; scientific research for medical purposes in the field of genetic therapy; Product development in the field of identifying immunotherapy therapy; research and development of technology in the field of immunotherapy therapy; scientific research for medical purposes in the field of immunotherapy therapy
Additional Information
Design Mark
The mark consists of a circle burst vector shape to the left of the stylized term GENETIQ.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
GENETIC
Classification
International Classes
005
009
042